PTC Therapeutics
PTCT
PTCT
201 hedge funds and large institutions have $3.81B invested in PTC Therapeutics in 2023 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 78 increasing their positions, 73 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding
Funds holding: 201 → 201 (0)
0.62% less ownership
Funds ownership: 106.95% → 106.33% (-0.62%)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
201
Holding in Top 10
4
Calls
$15.7M
Puts
$10.1M
Top Buyers
| 1 | +$89.5M | |
| 2 | +$71.6M | |
| 3 | +$56.6M | |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$25M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$21M |
Top Sellers
| 1 | -$58.1M | |
| 2 | -$25.8M | |
| 3 | -$22.9M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$21M |
| 5 |
BlackRock
New York
|
-$15.3M |